American Portfolios Advisors’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $174K | Sell |
8,403
-1,755
| -17% | -$36.4K | 0.01% | 1070 |
|
|
2022
Q2 | $236K | Sell |
10,158
-1,326
| -12% | -$30.8K | 0.01% | 965 |
|
|
2022
Q1 | $314K | Sell |
11,484
-779
| -6% | -$21.3K | 0.01% | 951 |
|
|
2021
Q4 | $437K | Hold |
12,263
| – | – | 0.01% | 799 |
|
|
2021
Q3 | $503K | Sell |
12,263
-554
| -4% | -$22.7K | 0.02% | 708 |
|
|
2021
Q2 | $513K | Buy |
12,817
+1
| +0% | +$40 | 0.02% | 696 |
|
|
2021
Q1 | $455K | Buy |
12,816
+40
| +0.3% | +$1.42K | 0.02% | 691 |
|
|
2020
Q4 | $397K | Buy |
12,776
+9,561
| +297% | +$297K | 0.02% | 632 |
|
|
2020
Q3 | $88.9K | Buy |
+3,215
| New | +$88.9K | 0.01% | 1099 |
|